<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Lipids Health Dis</journal-id><journal-title>Lipids in Health and Disease</journal-title><issn pub-type="epub">1476-511X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1476-511X-3-10</article-id><article-id pub-id-type="pmid">15157276</article-id><article-id pub-id-type="doi">10.1186/1476-511X-3-10</article-id><article-categories><subj-group subj-group-type="heading"><subject>Commentary</subject></subj-group></article-categories><title-group><article-title><italic>APOAV </italic>(T-1131&#x0003e;C) variant has no effect on mother's height in a large population study</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Hubacek</surname><given-names>Jaroslav A</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>jahb@medicon.cz</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Skodova</surname><given-names>Zdena</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>zdsk@medicon.cz</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Adamkova</surname><given-names>Vera</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>vead@medicon.cz</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Lanska</surname><given-names>Vera</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>vela@medicon.cz</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Bobkova</surname><given-names>Dagmar</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>dabq@medicon.cz</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Poledne</surname><given-names>Rudolf</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>rupo@medicon.cz</email></contrib></contrib-group><aff id="I1"><label>1</label>Institute of Clinical and Experimental Medicine, Prague, Czech Republic</aff><aff id="I2"><label>2</label>Centre for Experimental Cardiovascular Research, Prague, Czech Republic</aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>24</day><month>5</month><year>2004</year></pub-date><volume>3</volume><fpage>10</fpage><lpage>10</lpage><ext-link ext-link-type="uri" xlink:href="http://www.lipidworld.com/content/3/1/10"/><history><date date-type="received"><day>2</day><month>4</month><year>2004</year></date><date date-type="accepted"><day>24</day><month>5</month><year>2004</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2004 Hubacek et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement><copyright-year>2004</copyright-year><copyright-holder>Hubacek et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder></permissions><abstract><p>The important role of <italic>APOAV </italic>gene T-1131&#x0003e;C variant in determination of plasma triglyceride levels has been proved on many population studies. Recently, associations between C-1131 allele and higher mother's height as well as with longer fetal birth length were suggested.</p><p>In 1,305 females, aged between 28 and 67 years and having at least one child, we have analyzed a putative association between T-1131&#x0003e;C <italic>APOAV </italic>variant (analyzed by PCR and restriction analysis) and body height.</p><p>Mother's body height did not differ between T/T homozygotes (N = 1093, 162.5 &#x000b1; 6.5 cm) and C allele carriers (N = 212, 162.1 &#x000b1; 6.4 cm). Thus we have failed to confirm, that mothers with <italic>APOAV </italic>C-1131 allele are higher than T/T-1131 homozygotes.</p></abstract></article-meta></front><body><sec><title>Introduction</title><p>We read with interest the study by Ward <italic>et al</italic>. [<xref ref-type="bibr" rid="B1">1</xref>] on the association between the T-1131&#x0003e;C <italic>APOAV </italic>variant and plasma levels of triglycerides in pregnancy. In agreement with some previously published population's studies with different design [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B8">8</xref>], they described an association between higher levels of plasma triglyceride and the presence of C-1131 allele also in a group of healthy pregnant women. Additionally, they have found an interesting association between allele C-1131 and higher mother's height and as well as with fetal birth length.</p><p>The T-1131&#x0003e;C variant has been intensively studied over the last couple of years. The C allele is undoubtedly associated not just with higher plasma TG levels [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B7">7</xref>], but also with higher VLDL-TG levels [<xref ref-type="bibr" rid="B9">9</xref>] what could influence fetal growth [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>] and theoretically also final height of the body in adulthood, as suggested by Ward <italic>et al</italic>. [<xref ref-type="bibr" rid="B1">1</xref>].</p></sec><sec><title>Discussion</title><p>Using a previously described method [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B12">12</xref>], we analyzed the T-1131&#x0003e;C variant in a total of 1,367 unrelated Caucasians females aged 48.8 &#x000b1; 10.6 years in 2000/2001 recruited as a representative 1% population sample [<italic>Multinational monitoring of trends and determinants in cardiovascular diseases: MONICA Project</italic>, Manual of operations WHO/MNC 82.2, Nov 1983]. Written informed consent was obtained before the blood samples were taken and measurements being performed. 62 females have no children. In 1,305 females, having at least one child, we have analyzed a putative association between <italic>APOAV </italic>T-1131&#x0003e;C variant and body height by ANOVA. The size of the analyzed population minimized the chances of false negative or false positive results.</p><p>As mentioned before, standard association between elevated levels of plasma triglycerides and the presence of the C-1131 allele was found [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>].</p><p>In contrast to Ward <italic>et al</italic>. [<xref ref-type="bibr" rid="B1">1</xref>], we found no association between the T-1131&#x0003e;C variant in the <italic>APOAV </italic>gene and mother's body height, see Table <xref ref-type="table" rid="T1">1</xref>. Thus the association described by Ward <italic>et al</italic>. [<xref ref-type="bibr" rid="B1">1</xref>] need not be generally valid.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p><italic>APOAV </italic>T-1131&#x0003e;C variant and height in women</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><italic>APOAV </italic>genotype</td><td align="center">T-1131T</td><td align="center">+ C-1131</td></tr></thead><tbody><tr><td align="left">N</td><td align="center">1093</td><td align="center">212</td></tr><tr><td align="left">Height (cm)</td><td align="center">162.5 &#x000b1; 6.5</td><td align="center">162.1 &#x000b1; 6.4</td></tr></tbody></table><table-wrap-foot><p>Data are presented as means &#x000b1; s. d. No significant association was found.</p></table-wrap-foot></table-wrap><p>Plasma triglycerides represent the most important source of fatty acids utilized by fetus through pregnancy. About 50% of these fatty acids are derived from maternal circulation [<xref ref-type="bibr" rid="B13">13</xref>]. It has been found that maternal VLDL-TG concentrations are positively correlated with birth weight [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. In respect of these findings the same effect of VLDL-TG concentrations on birth length could be supposed. However results reveal that birth length seemed to be affected by many maternal factors [<xref ref-type="bibr" rid="B10">10</xref>] shading expected effect of TG.</p><p>Nevertheless, adult body height, which slightly correlate with birth length, although undoubtedly genetically determined, will be in last century strongly influenced by abundant availability of food sources in industrially developed countries and this environmental effect could mask the influence of the genes.</p></sec><sec><title>Conclusions</title><p>More than 1300 unrelated Caucasian females were included in this study. We conclude that the T-1131&#x0003e;C variant in the <italic>APOAV </italic>gene has no general effect on mother's body height. Nevertheless, <italic>APOAV </italic>gene and its variants [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B14">14</xref>] remain to be candidate gene for genetic determination of newborn's length/weight.</p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>KJ</given-names></name><name><surname>Shields</surname><given-names>B</given-names></name><name><surname>Knight</surname><given-names>B</given-names></name><name><surname>Salzmann</surname><given-names>MB</given-names></name><name><surname>Hattersley</surname><given-names>AT</given-names></name><name><surname>Frayling</surname><given-names>TM</given-names></name></person-group><article-title>Genetic variants in Apolipoprotein AV alter triglyceride concentrations in pregnancy</article-title><source>Lipids Health Dis</source><year>2003</year><volume>2</volume><fpage>9</fpage><pub-id pub-id-type="pmid">14613578</pub-id><pub-id pub-id-type="doi">10.1186/1476-511X-2-9</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pennacchio</surname><given-names>LA</given-names></name><name><surname>Olivier</surname><given-names>M</given-names></name><name><surname>Hubacek</surname><given-names>JA</given-names></name><name><surname>Cohen</surname><given-names>JC</given-names></name><name><surname>Cox</surname><given-names>DR</given-names></name><name><surname>Fruchart</surname><given-names>JC</given-names></name><name><surname>Krauss</surname><given-names>RM</given-names></name><name><surname>Rubin</surname><given-names>EM</given-names></name></person-group><article-title>An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing</article-title><source>Science</source><year>2001</year><volume>294</volume><fpage>169</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">11588264</pub-id><pub-id pub-id-type="doi">10.1126/science.1064852</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pennacchio</surname><given-names>LA</given-names></name><name><surname>Olivier</surname><given-names>M</given-names></name><name><surname>Hubacek</surname><given-names>JA</given-names></name><name><surname>Krauss</surname><given-names>RM</given-names></name><name><surname>Rubin</surname><given-names>EM</given-names></name><name><surname>Cohen</surname><given-names>JC</given-names></name></person-group><article-title>Two independent apolipoprotein AV haplotypes influence human plasma triglyceride levels</article-title><source>Hum Mol Genet</source><year>2002</year><volume>11</volume><fpage>3031</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12417524</pub-id><pub-id pub-id-type="doi">10.1093/hmg/11.24.3031</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nabika</surname><given-names>T</given-names></name><name><surname>Nasreen</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>S</given-names></name><name><surname>Masuda</surname><given-names>J</given-names></name></person-group><article-title>The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese</article-title><source>Atherosclerosis</source><year>2002</year><volume>165</volume><fpage>201</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12417270</pub-id><pub-id pub-id-type="doi">10.1016/S0021-9150(02)00252-6</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hubacek</surname><given-names>JA</given-names></name><name><surname>Skodova</surname><given-names>Z</given-names></name><name><surname>Adamkova</surname><given-names>V</given-names></name><name><surname>Lanska</surname><given-names>V</given-names></name><name><surname>Poledne</surname><given-names>R</given-names></name></person-group><article-title>The influence of APOAV polymorphisms (T-1131&#x0003e;C and S19&#x0003e;W) on plasma triglyceride levels and risk of myocardial infarction</article-title><source>Clin Genet</source><year>2004</year><volume>65</volume><fpage>126</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">14984471</pub-id><pub-id pub-id-type="doi">10.1111/j.0009-9163.2004.00199.x</pub-id></citation></ref><ref id="B6"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Hubacek</surname><given-names>JA</given-names></name><name><surname>Skodova</surname><given-names>Z</given-names></name><name><surname>Adamkova</surname><given-names>V</given-names></name><name><surname>Vrablik</surname><given-names>M</given-names></name><name><surname>Horinek</surname><given-names>A</given-names></name><name><surname>Lanska</surname><given-names>V</given-names></name><name><surname>Ceska</surname><given-names>R</given-names></name><name><surname>Poledne</surname><given-names>R</given-names></name></person-group><article-title>APOAV polymorphisms (T-1131/C and Ser19/Trp) influence plasma triglyceride levels and risk of myocardial infarction</article-title><source>Exp Clin Cardiol</source><year>2004</year><comment></comment></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Talmud</surname><given-names>PJ</given-names></name><name><surname>Hawe</surname><given-names>E</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Olivier</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>GJ</given-names></name><name><surname>Rubin</surname><given-names>EM</given-names></name><name><surname>Pennacchio</surname><given-names>LA</given-names></name><name><surname>Humphries</surname><given-names>SE</given-names></name></person-group><article-title>Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides</article-title><source>Hum Mol Genet</source><year>2002</year><volume>11</volume><fpage>3039</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">12417525</pub-id><pub-id pub-id-type="doi">10.1093/hmg/11.24.3039</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seda</surname><given-names>O</given-names></name><name><surname>Sedova</surname><given-names>L</given-names></name></person-group><article-title>New apoliprotein A-V: comparative genomics meets metabolism</article-title><source>Physiol Res</source><year>2003</year><volume>52</volume><fpage>141</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12678656</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Talmud</surname><given-names>PJ</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Taskinen</surname><given-names>MR</given-names></name><name><surname>Frick</surname><given-names>MH</given-names></name><name><surname>Nieminen</surname><given-names>MS</given-names></name><name><surname>Kesaniemi</surname><given-names>YA</given-names></name><name><surname>Pasternack</surname><given-names>A</given-names></name><name><surname>Humphries</surname><given-names>SE</given-names></name><name><surname>Syvanne</surname><given-names>M</given-names></name></person-group><article-title>APOA5 gene variants, lipoprotein particle distribution and progression of coronary heart disease: results from the LOCAT study</article-title><source>J Lipid Res</source><year>2004</year><volume>45</volume><fpage>750</fpage><lpage>756</lpage><pub-id pub-id-type="pmid">14729863</pub-id><pub-id pub-id-type="doi">10.1194/jlr.M300458-JLR200</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>RA</given-names></name></person-group><article-title>Placental metabolism and transport of lipid</article-title><source>Fed Proc</source><year>1986</year><volume>45</volume><fpage>2519</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">3527761</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knopp</surname><given-names>RH</given-names></name><name><surname>Bergelin</surname><given-names>RO</given-names></name><name><surname>Wahl</surname><given-names>PW</given-names></name><name><surname>Walden</surname><given-names>CE</given-names></name></person-group><article-title>Relationships of infant birth size to maternal lipoproteins, apoproteins, fuels, hormones, clinical chemistries, and body weight at 36 weeks gestation</article-title><source>Diabetes</source><year>1985</year><volume>Suppl 2</volume><fpage>71</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3922827</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horinek</surname><given-names>A</given-names></name><name><surname>Vrablik</surname><given-names>M</given-names></name><name><surname>Ceska</surname><given-names>R</given-names></name><name><surname>Adamkova</surname><given-names>V</given-names></name><name><surname>Poledne</surname><given-names>R</given-names></name><name><surname>Hubacek</surname><given-names>JA</given-names></name></person-group><article-title>T-1131--&#x0003e;C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals</article-title><source>Atherosclerosis</source><year>2003</year><volume>167</volume><fpage>369</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">12818421</pub-id><pub-id pub-id-type="doi">10.1016/S0021-9150(03)00022-4</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nolan</surname><given-names>CJ</given-names></name><name><surname>Riley</surname><given-names>SF</given-names></name><name><surname>Sheedy</surname><given-names>MT</given-names></name><name><surname>Walstab</surname><given-names>JE</given-names></name><name><surname>Beischer</surname><given-names>NA</given-names></name></person-group><article-title>Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy</article-title><source>Diabetes Care</source><year>1995</year><volume>18</volume><fpage>1550</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8722050</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hubacek</surname><given-names>JA</given-names></name><name><surname>Adamkov&#x000e1;</surname><given-names>V</given-names></name><name><surname>Ceska</surname><given-names>R</given-names></name><name><surname>Poledne</surname><given-names>R</given-names></name><name><surname>Horinek</surname><given-names>A</given-names></name><name><surname>Vrablik</surname><given-names>M</given-names></name></person-group><article-title>New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels</article-title><source>Physiol Res</source><year>2004</year><volume>53</volume><fpage>225</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15046561</pub-id></citation></ref></ref-list></back></article> 